FDA
approval
· 2012-01-26
FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
Summary
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) to support an expanded indication for the treatment of urticaria (hives).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)